-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background gastrointestinal decompression is usually used in the treatment of non-narrow acute small intestine obstruction (NSASBO).
Although in previous studies, long tube (LT) placement of a combination nasal gastric tube (NGT-G) injection of pan-contrast glutamine is better than the use of NGT alone, there has been no study to compare LT and NGT-G, so the study aims to compare the differences in efficacy between the two.
method in this multicenter randomized controlled trial, researchers will be randomly assigned to RECEIVE LT or NGT-G treatment in patients with non-narrow intestinal obstruction (NSASBO) between July 2016 and November 2018.
the main endpoint is the non-surgical efficacy of NGT-G compared to LT.
results In this trial, a total of 223 patients were analyzed (LT group, n s 111; NGT-G group, n s 112). The non-surgical rate of the
LT group was 87.4%, the non-surgical rate in the NGT-G group was 91.1%, and the difference between NGT-G and LT was 3.7% (95.3% CI-5.55 to 12.91;
on the other hand, the non-surgical rate (76.8%) of the use of pure NGT-G alone represents a significantly lower non-surgical rate than the non-crossNGT-G non-surgical rate of non-follow-up LT (P - 0.039).
NGT-G had significantly less neutral surgery time than LT (1 min VS 25 minutes; P.lt;0.001), and there was no significant difference in mortality or hospital stay between the two groups.
concluded that NGT-G is an effective alternative to LT and can be used as a first-line treatment drug for NSASBO.
.